🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety profile, the effectiveness and the economic impact o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00513370
Treatments Being Tested
A Canadian study to evaluate early use of adalimumab after methotrexate fai...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01162421
Treatments Being Tested
This study is conducted to evaluate the short (12 Weeks) and long term (104...
Status
Completed
Location
141
Start Date
2011-12
Trial ID
NCT01500278
Treatments Being Tested
Aims: To study the efficacy and safety of adalimumab versus placebo in the...
Status
Unknown
Location
Kuopio University Hospital
Start Date
2007-03
Trial ID
NCT01510548
Treatments Being Tested
The purpose of the study is to compare the effectiveness and safety of FKB3...
Status
Completed
Location
Research Site
Start Date
2014-12
Trial ID
NCT02260791
The main objective of this study is to evaluate the safety of adalimumab in...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00775437
Treatments Being Tested
The primary objective of this study was to evaluate the tolerability and sa...
Status
Terminated
Location
Research Site
Start Date
2006-05
Trial ID
NCT00298272
Treatments Being Tested
The purpose of the study is to compare the long-term safety, effectiveness ...
Status
Completed
Location
Research Site
Start Date
2015-06-10
Trial ID
NCT02405780
The aim of the study is to demonstrate equivalent efficacy and similarity i...
Status
Completed
Location
Total Skin & Beauty Dermatology Center
Start Date
2013-12
Trial ID
NCT02016105
Treatments Being Tested
Loss of response of the Adalimumab biosimilar compared with the original dr...
Status
Terminated
Location
Hospital Universitario Virgen Macarena
Start Date
2019-10-10
Trial ID
NCT04131322
Treatments Being Tested